Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

Neola Medical invites to presentation of the Q4-report 2024

Neola Medical

Neola Medical AB (publ) invites to presentation of the Q4-report of 2024, Wednesday the 12th of February 2025 at 11:00 CET (11.00). The presentation will be held online as a webcast hosted by Finwire. The Q4-report will be published the same morning.

Neola Medical publishes the Q4-report in the morning the 12th of February 2025. We hereby invite investors, analysts, and journalists to a combined report presentation and webcast Wednesday the 12th of February 2025 at 11:00 CET (11.00). The report will be presented by CEO Hanna Sjöström and CFO David Folkesson.

Watch the presentation here: https://www.finwire.tv/webcast/neola-medical/year-end-report/ where you also can type in questions in advance and during the presentation that we will be answering live during the Q&A after the presentation.

For further questions after the presentation, contact CFO David Folkesson through below contact details.

The report and report presentation will be available at Neola Medical’s website:
https://www.neolamedical.com/investors/rapporter-och-finansiell-kalender/

For further information, contact:
Hanna Sjöström, CEO
e-mail: hanna.sjostrom@neolamedical.com
David Folkesson, CFO
e-mail: david.folkesson@neolamedical.com

About Neola Medical
Neola Medical AB (publ) develops revolutionizing medical technology device for non-invasive continuous lung monitoring and real-time alerts of life-threatening lung complications of preterm born infants. Immediate detection of complications provides the possibility of early treatment, improved health care and healthier lives for preterm born infants. The patented cutting-edge technology is developed at Lund University in Sweden and based on a spectroscopic method that measures lung volume changes and oxygen gas concentration. Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.

Attachments
Neola Medical invites to presentation of the Q4-report 2024

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team